非前列腺癌肿瘤:1445例患者中18F-DCFPyL PSMA PET/CT的检出率及摄取特征
除肾细胞癌外,非前列腺癌肿瘤均表现为无或低PSMA表达,而大多数非典型前列腺癌转移灶表现为中等或高PSMA表达。
要点
- 除肾细胞癌外,非前列腺癌肿瘤均无或低PSMA表达。
- 中等至高PSMA表达的非典型病灶除肾细胞癌外均为前列腺癌转移。
核心结论
- 18F-DCFPyL PSMA PET/CT对非前列腺癌肿瘤的检出率低。
- 除肾细胞癌及高背景表达器官外,中等至高PSMA表达病灶均为前列腺癌转移。
研究设计与样本
- 回顾性分析1445例连续18F-DCFPyL PSMA PET/CT检查,由经验丰富的放射科和核医学科医师判读,并与病历、活检及专用影像对照。
主要发现
- 68例中,非典型前列腺癌转移8/68(11.8%),非前列腺癌肿瘤17/68(25.0%),不确定病灶29/68(42.6%),良性14/68(20.6%)。
- 占全队列比例分别为:非典型前列腺癌转移8/1445(0.6%),非前列腺癌肿瘤17/1445(1.2%),不确定29/1445(2.0%),良性14/1445(1.0%)。
- 除肾细胞癌外,非前列腺癌肿瘤无或低PSMA表达,不确定和良性病灶呈类似趋势。
- 大多数非典型前列腺癌转移灶表现为中等或高PSMA表达。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: With increasing use of PSMA PET/CT in the staging and restaging of prostate cancer (PCa), the identification of non-prostate cancer tumours (NPCaT) has become an increasing clinical dilemma. Atypical presentations of PSMA expression in prostate cancer and expression in NPCaT are not well established. Understanding the normal and abnormal distribution of PSMA expression is essential in preparing clinically relevant reports and in guiding multidisciplinary discussion and decisions. METHODS: Retrospective review of 1445 consecutive 18F-DCFPyL PSMA PET/CT studies by experienced radiologists and nuclear medicine physicians. Lesions indeterminate for PCa were identified. Correlation was made with patient records, biopsy results, and dedicated imaging. Lesions were then categorized into four groups: 1. Confirmed prostate cancer, metastases, 2. NPCaT 3. Benign, and 4. Indeterminate lesions. RESULTS: 68/1445 patients had lesions atypical for prostate cancer metastases. These comprised 8/68 (11.8%) atypical prostate cancer metastases, 17/68 (25.0%) NPCaT, 29/68 (42.6%) indeterminate, and 14/68 (20.6%) benign. In the context of the entire cohort, these are adjusted to 8/1445 (0.6%), 17/1445 (1.2%), 29/1445 (2.0%), and 14/1445 (1.0%) respectively. With the exception of Renal Cell Carcinoma (RCC), NPCaT demonstrated no or low PSMA expression. A similar trend was also observed for indeterminate and benign lesions. Conversely, most atypical PCa metastases demonstrated intermediate or high PSMA expression. CONCLUSION: 18F-DCFPyL PSMA PET/CT detection of NPCaT is low. Lesions demonstrating intermediate to high PSMA expression were exclusively prostate cancer metastases, aside from RCC, and lesions detected in organs with high background expression.
引用
- Perry E, Talwar A, Sharma S, et al. Non-prostate cancer tumours: incidence on 18F-DCFPyL PSMA PET/CT and uptake characteristics in 1445 patients. Eur J Nucl Med Mol Imaging. 2022. PMID: 35254481. doi:10.1007/s00259-022-05721-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。